- Evaluation of Asymmetric Dimethylarginine, Malondialdehyde, and Vitamin Levels of Borderline Personality Disorder Patients With and Without Self-Mutilation
-
Telo S, Baykara S
- KMID: 2549072
- Psychiatry Investig.
- 2023 Dec;20(12):1142-1147.
- doi: 10.30773/pi.2023.0250
Objective Believing that oxidative stress may be increased in borderline personality disorder (BPD) patients with self-mutilating behaviors (SMB), we aimed to measure serum asymmetric dimethylarginine (ADMA) and malondialdehyde (MDA) levels... -
- CITED
-
- Close
- SHARE
-
- Close
